Selective PRMT5 Inhibitors Suppress Human CD8(+) T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA
- Resource Type
- Journal
- Source
MOLECULAR CANCER THERAPEUTICS ; FEB 2020, 19 2, p409-p419, 11p.- Subject
- Language
- English
- ISSN
- 15388514